A Groundbreaking Event in Vienna
This April, Vienna becomes the epicenter for infectious disease innovation as Gradientech presents its groundbreaking QuickMIC® system at ESCMID Global 2025. Taking place from April 11th to 15th, this year’s congress anticipates over 16,000 healthcare professionals and researchers, eager to exchange knowledge and explore the latest developments in clinical microbiology.
Unveiling Rapid AST Breakthroughs
Gradientech debuts compelling data through three new abstracts that explore the QuickMIC system within varied resistance contexts. These studies not only highlight the system’s ability to rapidly assess antibiotic susceptibility for urosepsis but also tackle the complexity of testing for cefiderocol—a notorious challenge for conventional methods. SelectScience
A Leap Forward in Diagnostic Technology
Marked by precision and speed, the latest version of QuickMIC offers more than just results. According to CEO Sara Thorslund, the system’s updated design incorporates an integrated screen solution, minimizing lab space required while boosting efficiency. “This platform positions us to shift the paradigm in antimicrobial susceptibility testing,” notes Thorslund, emphasizing QuickMIC’s potential to transform diagnostics.
Immersing Professionals in Cutting-Edge Science
Positioned at Booth E36 within the Messe Wien Exhibition & Congress Center, Gradientech transforms its booth into a hub for innovation, inviting attendees to experience QuickMIC’s potential firsthand. The event promises to be a confluence of ideas, as clinicians and microbiologists worldwide converge to discuss future directions in patient care.
Visit Gradientech at ESCMID Global 2025
Discover QuickMIC and Elevate Diagnostics
April 11th-15th Messe Wien Exhibition & Congress Center, Vienna Gradientech Booth E36, Exhibition Hall
Engage with the latest advancements straight from the minds of experts as Gradientech furthers its mission to enhance diagnostics. With far-reaching implications for patient outcomes, the QuickMIC system exemplifies the pinnacle of modern microbiological testing.
With these innovations, ESCMID Global 2025 stands as a testament to the collaborative spirit fueling advances in clinical microbiology and infectious diseases. Don’t miss your chance to be part of this groundbreaking journey.